Industry News (Patents and Technology)

U.S. Patent Office Allows Patent on AIDS Diagnostic Kit

Published in TB and Outbreaks Week, September 15th, 1997

Cel-Sci Corp., Alexandria, Virginia, announced the allowance of a U.S. patent on the "diagnostic method and test kit for the serological detection of [HIV]."

The test kit is based upon the measurement of antibodies against a region (HGP-30) of the core of HIV.

As part of the same research program, Cel-Sci Corp. has been developing the HGP-30 HIV vaccine. This vaccine has been tested in over 60 individuals and is expected to go into Phase II studies soon.

Cel-Sci Corp. has been developing Multikine for the treatment of cancers and other immunodeficiency diseases. In addition, it is developing the HGP-30 HIV vaccine/treatment and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1997-09-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry